It simply comes down to the quality of the project and the quality of management.
This deal gets Brett Montgomery set in the sub-underwriting. Brett has a good reputation and he knows his way around a gold mine. He is not part of the old guard so he has no ego invested in the status quo. He is smart enough to already know what the results are as he has seen the samples and is party to the preliminary results on the "dolerite". We can all whinge, but this is how it works. If you want a seriously committed MD then they need skin in the game. At 2 cents he is thieving his shares if punters don't stump up. Brett is well regarded by Allied. They trust him. He is not going to over promise and under deliver. It's in every ongoing shareholders interest for the MD to get set so that his interests align with ours.
I think that the company has been less than forthright in its prosecution of continuous disclosure obligations. I am not suggesting that they are breaking the law or not disclosing what they know - just perhaps they are making sure of the information so they can happily then be "surprised" by the assays on the K1 and Dolerite cores. Hopefully we can all be surprised in a good way!
If you have good management with serious cash at stake and the project is good (as I hope), then logic says that you should see some pretty good recovery from 2 cents. Do your own research and don't rely on my ramblings.
TAM Price at posting:
2.5¢ Sentiment: Buy Disclosure: Held
